1. Home
  2. PMAX vs MRNS Comparison

PMAX vs MRNS Comparison

Compare PMAX & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • MRNS
  • Stock Information
  • Founded
  • PMAX 2019
  • MRNS 2003
  • Country
  • PMAX Hong Kong
  • MRNS United States
  • Employees
  • PMAX N/A
  • MRNS N/A
  • Industry
  • PMAX
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • MRNS Health Care
  • Exchange
  • PMAX Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • PMAX 32.0M
  • MRNS 29.9M
  • IPO Year
  • PMAX 2024
  • MRNS 2014
  • Fundamental
  • Price
  • PMAX $0.42
  • MRNS $0.55
  • Analyst Decision
  • PMAX
  • MRNS Buy
  • Analyst Count
  • PMAX 0
  • MRNS 12
  • Target Price
  • PMAX N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • PMAX 4.4M
  • MRNS 1.2M
  • Earning Date
  • PMAX 02-21-2025
  • MRNS 03-04-2025
  • Dividend Yield
  • PMAX N/A
  • MRNS N/A
  • EPS Growth
  • PMAX N/A
  • MRNS N/A
  • EPS
  • PMAX 0.04
  • MRNS N/A
  • Revenue
  • PMAX $5,970,263.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • PMAX N/A
  • MRNS $14.97
  • Revenue Next Year
  • PMAX N/A
  • MRNS $57.65
  • P/E Ratio
  • PMAX $10.72
  • MRNS N/A
  • Revenue Growth
  • PMAX 30.05
  • MRNS 1.63
  • 52 Week Low
  • PMAX $0.34
  • MRNS $0.22
  • 52 Week High
  • PMAX $4.70
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • MRNS 70.71
  • Support Level
  • PMAX N/A
  • MRNS $0.54
  • Resistance Level
  • PMAX N/A
  • MRNS $0.55
  • Average True Range (ATR)
  • PMAX 0.00
  • MRNS 0.00
  • MACD
  • PMAX 0.00
  • MRNS -0.01
  • Stochastic Oscillator
  • PMAX 0.00
  • MRNS 100.00

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: